Lihuai Qin Email

Assistant Director . Cullgen

Current Roles

Employees:
35
Revenue:
$2.7M
About
Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Our technology, which we call uSMITE™ (ubiquitin-mediated, small molecule-induced target elimination) has the potential to address a broad range of intracellular disease targets, including those representing the up to 80% of proteins that cannot be addressed by existing small molecule therapies, commonly referred to as undruggable targets. In addition to using our uSMITE™ platform to build our own pipeline of protein degradation product candidates, we are also developing a portfolio of novel E3 ligands. You can learn more information about Cullgen on our website: www.Cullgen.com
Cullgen Address
12730 High Bluff Drive
San Diego, CA
Cullgen Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.